TipHub

195.01

+1.59 +0.82%

29 Jul 2026

NSE Listed · Pharmaceuticals

Piramal Pharma Limited (PPLPHARMA)

Volume: 89,12,695Avg Vol 1W: 88,16,028Avg Vol 1M: 76,93,73652W Range:132.3210.5
Market Cap₹25,963 Cr
Current Price₹195.01
Previous Close₹193.42
High / Low (52w)₹210.5 / ₹132.3
Volume89,12,695
Avg Vol (1W)88,16,028
Avg Vol (1M)76,93,736
Stock P/E
Book Value₹61.5
Dividend Yield0%
ROE-3.58%
ROA-1.81%
Revenue (TTM)
Revenue Growth11.99%
Profit Margin-3.68%
Total Debt₹3,214 Cr
Shares Outstanding133 Cr
Face Value₹10
EPS (TTM)₹-0.07
P/B3.17
Debt / Equity0.7
50 DMA₹172.5
200 DMA₹170.36
Day change+0.82%
Price Chart
195.01 5.16% · 1Y
2251339.3Cr
2025-07-29
2026-07-29

20-day avg volume: 80.2L shares

Pros
  • Company is almost debt-free.
  • Revenue grew 510% YoY.
Cons
  • Company is loss-making at the latest annual result.
Quarterly Results
MetricJun 2024Sept 2024Dec 2024Mar 2025Jun 2025Sept 2025Dec 2025Mar 2026
Revenue₹1,951 Cr₹2,242 Cr₹2,204 Cr₹2,754 Cr₹1,934 Cr₹2,044 Cr₹2,140 Cr₹2,752 Cr
EBITDA₹39 Cr₹211 Cr₹153 Cr₹360 Cr₹-32 Cr₹21 Cr₹26 Cr₹288 Cr
Net Profit₹-89 Cr₹23 Cr₹4 Cr₹154 Cr₹-82 Cr₹-99 Cr₹-136 Cr₹-9 Cr
EPS
Profit & Loss (Annual)
MetricDec 2024Mar 2025Mar 2025Jun 2025Sept 2025Dec 2025Mar 2026Mar 2026
Revenue₹1,248 Cr₹1,690 Cr₹9,286 Cr₹970 Cr₹1,127 Cr₹1,196 Cr₹9,082 Cr₹1,489 Cr
EBITDA₹189 Cr₹395 Cr₹763 Cr₹166 Cr₹268 Cr₹199 Cr₹304 Cr₹417 Cr
Net Profit₹119 Cr₹277 Cr₹91 Cr₹113 Cr₹196 Cr₹129 Cr₹-326 Cr₹262 Cr
EPS0.68-2.46
Balance Sheet
MetricMar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Total Assets₹10,900 Cr₹12,797 Cr₹14,523 Cr₹15,312 Cr₹15,678 Cr₹17,965 Cr
Total Liabilities₹5,295 Cr₹6,100 Cr₹7,749 Cr₹7,400 Cr₹7,552 Cr₹9,802 Cr
Equity₹5,605 Cr₹6,697 Cr₹6,774 Cr₹7,911 Cr₹8,125 Cr₹8,163 Cr
Total Debt
Cash Flow
MetricMar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating₹742 Cr₹936 Cr₹673 Cr₹1,161 Cr₹1,227 Cr₹1,863 Cr
Investing₹-4,480 Cr₹-1,812 Cr₹-1,339 Cr₹-434 Cr₹-477 Cr₹-826 Cr
Financing₹3,977 Cr₹794 Cr₹818 Cr₹-422 Cr₹-441 Cr₹-39 Cr
Free Cash Flow₹742 Cr₹936 Cr₹673 Cr₹1,161 Cr₹1,227 Cr₹1,863 Cr
Shareholding
Promoter 34.8% Institutions 27.09% Public 38.11%
Efficiency & Working Capital
ROCE12.3%
Interest Coverage1
Dividend Payout
Debtor Days89 d
Inventory Days126 d
Payable Days102 d
Cash Conversion Cycle113 d
Working Capital Days215 d
Shareholding Details

As of 2026-06-30

Promoter34.8%
FII12.5%
DII14.6%
Institutions27.1%
Public38.1%
Promoter Pledge0%
No. of Shareholders4,61,096
Shareholding Pattern

Quarterly — figures in %. Latest 12 quarters.

PeriodSept 2023Dec 2023Mar 2024Jun 2024Sept 2024Dec 2024Mar 2025Jun 2025Sept 2025Dec 2025Mar 2026Jun 2026
Promoters35%35%35%34.9%34.9%34.9%34.9%34.9%34.9%34.9%34.9%34.8%
FIIs32.4%32.5%30.6%31.4%31.7%31.7%31.5%30.9%30.3%29.7%30.2%12.5%
DIIs8%9.7%12.1%13%13.8%14.1%14.8%14.3%14.9%15.7%15.6%14.6%
Public24.6%22.8%22.3%20.7%19.5%19.3%18.8%20%20%19.8%19.4%38.1%
Promoter Pledge0%0%0%0%0%0%0%0%0%0%0%0%
No. of Shareholders3,00,6062,92,3122,97,9963,06,3983,59,7514,18,4424,32,8434,58,4304,62,5114,53,8304,50,6614,61,096
Returns History (ROE / ROCE / ROA)
PeriodROEROCEROAP/E
202603
Major Shareholders (>1%)
NameCategoryStakeShares
The Sri Krishna Trust (through Its Trustee Mr. Ajay G Piramal And Dr. (mrs.) Swati A. Piramal)Shareholding of Promoter and Promoter Group26.5%35.29 Cr
Ca Alchemy InvestmentsPublic Shareholding17.9%23.87 Cr
Hdfc Trustee Company Limited-hdfc Flexi Cap FundPublic Shareholding7.7%10.23 Cr
V3 Designs LlpShareholding of Promoter and Promoter Group3.2%4.30 Cr
Prl Realtors LlpShareholding of Promoter and Promoter Group3%3.98 Cr
East Bridge Capital Master Fund I LtdPublic Shareholding2%2.66 Cr
Indiahold LimitedPublic Shareholding1.3%1.73 Cr
Piramal Welfare TrustShareholding of Promoter and Promoter Group0.8%1.06 Cr
Semplice Corporate Solutions Private Limited (formerly Known As Aasan Corporate Solutions Private LiShareholding of Promoter and Promoter Group0.7%89,31,097
The Ajay G. Piramal FoundationShareholding of Promoter and Promoter Group0.3%43,75,937
Mr. Anand PiramalShareholding of Promoter and Promoter Group0.1%8,74,082
Anand Piramal TrustShareholding of Promoter and Promoter Group0.1%6,17,884
Mr. Ajay G. PiramalShareholding of Promoter and Promoter Group0%5,47,326
Nandini Piramal TrustShareholding of Promoter and Promoter Group0%5,44,325
Mr. Peter DeyoungShareholding of Promoter and Promoter Group0%4,32,000
Ms. Nandini PiramalShareholding of Promoter and Promoter Group0%2,90,418
Ms. Anya Piramal DeyoungShareholding of Promoter and Promoter Group0%1,92,000
Master Dev Piramal DeyoungShareholding of Promoter and Promoter Group0%1,92,000
Mr. Ajay G. Piramal (karta Of Ajay G. Piramal Huf)Shareholding of Promoter and Promoter Group0%28,857
Late Mrs. Lalita G. PiramalShareholding of Promoter and Promoter Group0%4,936
Dr. (mrs.) Swati A. PiramalShareholding of Promoter and Promoter Group0%9,313
Piramal Corporate & Management Services Pvt. Ltd.Shareholding of Promoter and Promoter Group0%0
Anutham Realty Private LimitedShareholding of Promoter and Promoter Group0%0
Swati Piramal TrustShareholding of Promoter and Promoter Group0%0
The Gulita TrustShareholding of Promoter and Promoter Group0%0
Board of Directors
NameDesignationYear
Nandini PiramalChairperson / Executive Director2026
PETER D DEYOUNGExecutive Director & CEO2026
Vivek ValsarajExecutive Director & CFO2026
Nathalie LeitchIndependent Non Exe. Director2026
Amit JainNon-Exec & Non-Independent Dir2026
Jairaj Manohar PurandareIndependent Non Exe. Director2026
Sridhar GorthiIndependent Non Exe. Director2026
Peter StevensonIndependent Non Exe. Director2026
Vibha Paul RishiIndependent Non Exe. Director2026
AMIT SONIIndependent Non Exe. Director2026
Maneesh SharmaCompany Sec. & Compli. Officer2026
Capital Structure (₹ Cr)
YearFace ValueAuthorisedIssuedPaid-up
2026₹102,6291,3271,327
Corporate Actions
TypeDateValueRemark
forthcoming2026-07-29Board Meetings
dividend2025-07-16₹0.14 (1.4%)Final
Related-Party Transactions (₹ Cr)
YearSubsidiariesAssociatesJVKMPOthersTotal
202611,0111540265011,241
20262,564000502,614
20267,7301802607,774
Substantial Acquisitions (SAST)

6 disclosure(s)

Market26/06/2025 · 2,65,48,576
Market29/07/2024 · 2,72,82,116
Creation Of Encumbrance28/05/2024 ·
Market14/03/2024 · 8,20,662
Creation Of Encumbrance11/03/2024 ·
Encumbrance Created22/02/2024 ·
Company Information
Incorporated2020
ChairmanNandini Piramal
AuditorSuresh Surana & Associates LLP
Investor Email[email protected]
🌐 www.piramalpharma.com

📍 Ananta Bldg Piramal Corporate, Park LBS Marg Kurla west, Mumbai, Maharashtra, 400070

Technical AnalysisPremium

Technical analysis (Premium)

Log in to see RSI, MACD, moving averages, oscillators and pivot levels for this stock.

More stocks

Prices are delayed/indicative; pros & cons are AI generated. Informational only — not investment advice. ← Back to search